Vaccinex (VCNX.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

May27

Vaccinex to Present New Clinical Data on Pepinemab at ASCO Annual Meeting

12:47

Apr21

Vaccinex to Present New Mechanism of Immune Therapy Enhancement by Pepinemab at AACR Annual Meeting

12:47

Apr16

Vaccinex released FY2024 Q4 earnings on April 15, 2025 (EST) with actual revenue of USD 213 K and EPS of USD -1.0466

03:00

Vaccinex released FY2024 Annual Earnings on April 15 (EST), actual revenue USD 601K, actual EPS USD -8.8777

03:00

Nov15

Vaccinex released FY2024 Cumulative Q3 Earnings on November 14, 2024 (EST), with Revenue of 388,000 USD and EPS of -8.8661

04:00

Vaccinex released FY2024 Q3 earnings on November 14 (EST), with actual revenue of 52 K USD and EPS of -2.8279 USD

04:00

Schedules & Filings

Schedules

Filings

Apr15

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 213 K, Net Income -3.374 M, EPS -1.0466

Nov14

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 52 K, Net Income -5.732 M, EPS -2.8279

Aug14

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 232 K, Net Income -5.631 M, EPS -3.0981

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change